Evaluation of Hepatitis C Virus Transmission Through Endoscopy Procedures in the Country of Georgia.
Supporting Files
-
April 2025
-
Available in CDC Stacks on April 01, 2026, 12:00 AM
File Language:
English
Details
-
Alternative Title:Journal of Viral Hepatitis, 2025, v. 32, no. 4: Evaluation of Hepatitis C Virus Transmission Through Endoscopy Procedures in the Country of Georgia.
-
Journal Article:Journal of Viral Hepatitis
-
Personal Author:
-
Description:Exposure to healthcare procedures might be a source of hepatitis C virus (HCV) transmission in Georgia, one of the few countries currently on track to eliminate hepatitis C. While there has been a history of iatrogenic transmission of HCV, the risk of HCV transmission related to endoscopic procedures has not been previously assessed in Georgia. The goal of this study was to assess HCV seroconversion among individuals undergoing endoscopic procedures to estimate the relative role and incidence of HCV infection attributable to endoscopic procedures. A prospective cohort study was conducted in four endoscopy units in two cities (Tbilisi and Kutaisi) of Georgia during April-September, 2021. Recruitment of study participants was conducted using convenience sampling, and every eligible patient was approached and invited to participate in the study. Study population included adults (age ≥ 18 years) who received an endoscopic procedure (gastroscopy, colonoscopy and bronchoscopy) in inpatient or outpatient unit at the study sites. HCV antibody (anti-HCV) testing was conducted using rapid diagnostic test (RDT) on the same day they underwent the endoscopic procedure. Patients with a non-reactive anti-HCV baseline test were retested after 6 months. Patients with reactive baseline tests were excluded from the study and linked to further testing and care. Participants with a reactive result on follow-up RDTs were retested using a lab-based anti-HCV and HCV ribonucleic acid (RNA) test. A total of 981 HCV antibody non-reactive participants were enrolled; 590 (64.8%) of them were reached and retested after 6 months. At retesting, two out of 590 (0.3%) individuals had a reactive anti-HCV result on RDT and both were negative on laboratory-based anti-HCV and HCV RNA tests. Based on the results of this study, endoscopic procedures were not shown to contribute to HCV transmission in Georgia.
-
Content Notes:Author manuscript
-
Subjects:
-
Keywords:
-
Source:Journal of Viral Hepatitis, 2025, v. 32, no. 4
-
DOI:
-
ISSN:1352-0504 ; 1365-2893
-
Pubmed ID:39400546
-
Pubmed Central ID:PMC11885007
-
Document Type:
-
Funding:
-
Genre:
-
Pages in Document:e14022 (7 pdf pages)
-
Volume:32
-
Issue:4
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:6842aa2ba16330504f78a5af66554adcca028696d3ed4cb0d303daadde66e3cc8c86adfcb52953fcdf4289e92dfaf66f352f208cce904de1f43708760d0c8944
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access